Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New thoughts on resistance to chemotherapy.

J H Goldie

    Hospital Practice (Office Ed.)
    |May 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Cancer treatment failure may stem from drug resistance due to tumor cell mutations. A "front-loaded" approach using multiple effective agents at maximum doses is proposed as the best strategy for initial cancer therapy.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Drug resistance in cancer: a perspective.

    Cancer metastasis reviews·2002
    Same author

    Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2000
    Same author

    The use of conventional salvage chemotherapy before dose-intensive cytotoxic therapy and autologous transplantation for aggressive-histology lymphoma: a case for re-evaluation.

    Leukemia & lymphoma·1997
    Same author

    Toxicity studies in thymidine kinase-deficient herpes simplex virus therapy for malignant astrocytoma.

    Journal of neurosurgery·1996
    Same author

    Adjuvant therapy for breast cancer.

    The New England journal of medicine·1994
    Same author

    Modelling the process of drug resistance.

    Lung cancer (Amsterdam, Netherlands)·1994

    Area of Science:

    • Oncology
    • Cancer Biology
    • Pharmacology

    Background:

    • Kinetic theories of tumor growth inadequately explain treatment failure.
    • Cancer drug resistance is a significant clinical challenge.

    Purpose of the Study:

    • To propose an alternative explanation for cancer treatment failure.
    • To suggest an optimized first-line cancer treatment strategy.

    Main Methods:

    • Review of existing kinetic tumor growth models.
    • Hypothesis generation based on somatic mutation theory in cancer.

    Main Results:

    • Kinetic models do not fully account for treatment resistance.
    • Somatic mutations in tumor cells are proposed as a key driver of drug resistance.

    Conclusions:

    • A
    • front-loaded
    • first-line treatment strategy is recommended.
    • Utilizing multiple effective agents at the highest possible dosages is advocated.